Impact of Early Renal Recovery on Survival After Cardiac Surgery-Associated Acute Kidney Injury

Size: px
Start display at page:

Download "Impact of Early Renal Recovery on Survival After Cardiac Surgery-Associated Acute Kidney Injury"

Transcription

1 CARDIOTHORACIC ANESTHESIOLOGY: The Annals of Thoracic Surgery CME Program is located online at To take the CME activity related to this article, you must have either an STS member or an individual non-member subscription to the journal. Impact of Early Renal Recovery on Survival After Cardiac Surgery-Associated Acute Kidney Injury Madhav Swaminathan, MD, Christopher C.C. Hudson, FRCPC, Barbara G. Phillips-Bute, PhD, Uptal D. Patel, MD, Joseph P. Mathew, MD, Mark F. Newman, MD, Carmelo A. Milano, MD, Andrew D. Shaw, MB, FRCA, and Mark Stafford-Smith, MD, FRCPC Division of Cardiothoracic Anesthesiology, Department of Anesthesiology; Department of Medicine and the Duke Clinical Research Institute, and Department of Surgery, Duke University Medical Center, Durham, North Carolina Background: Cardiac surgery-associated acute kidney injury (CSA-AKI) is a major postoperative complication. Although some early recovery is common, its effect on long-term outcomes is unclear. We tested the hypothesis that early renal recovery after CSA-AKI is independently associated with improved long-term survival. Methods: Data were examined for 10,275 consecutive patients undergoing isolated coronary artery bypass grafting from 1996 to Patients with CSA-AKI were identified, defined as a peak postoperative creatinine level exceeding 50% above baseline. Renal recovery was characterized using postoperative creatinine values. The recovery variable with the strongest association with 1-year survival was selected and validated internally. The independent association of early renal recovery with long-term survival during a 10-year follow-up was assessed with Cox proportional hazards modeling. Results: CSA-AKI occurred in 1113 patients (10.8%). The renal recovery variable with the strongest association with 1-year survival was the percentage decrease in creatinine 24 hours after its peak value (PD24; C index, 0.72; p 0.002). Cox proportional hazards analysis showed a significant negative association between PD24 and long-term mortality (0.82 hazard ratio for each 10% change). Conclusions: Early recovery of renal function is associated with improved long-term survival after CSA-AKI. This variable is clinically useful because it occurs immediately after the peak creatinine level and simultaneously helps define the severity of AKI and the magnitude of recovery. Given the high risk of death associated with postoperative AKI, early renal recovery seems to offer a distinct survival benefit and may represent an important therapeutic focus. (Ann Thorac Surg 2010;89: ) 2010 by The Society of Thoracic Surgeons Accepted for publication Dec 9, Address correspondence to Dr Swaminathan, Box 3094 Anesthesiology, Duke University Medical Center, Durham, NC 27710; swami001@mc.duke.edu. Cardiac surgery-associated acute kidney injury (CSA- AKI) remains a major postoperative complication that is associated with a high risk of short-term and long-term death [1 3]. Although epidemiologic studies have used variable metrics to define CSA-AKI, these are almost universally based on perioperative changes in serum creatinine values. Despite abundant data on the prognostic importance of AKI, there is limited information on early recovery of renal function after the creatinine level has reached its postoperative peak. The kidney is remarkable in its ability to almost completely recover from a total loss of function. Investigators have reported favorable outcomes when kidneys demonstrate some recovery of function after acute failure [4, 5]; however, recovery of renal function has been studied mainly in terms of freedom from dialysis [4 7]. The effect of early recovery from smaller but still significant decrements in renal function remains largely unknown. Emerging data suggest that endogenous repair mechanisms may enhance recovery of kidney function after an acute insult. The recovery paradigm is important because it represents a potential focus for interventions that may modify the effect of AKI on death. Although the predictive value of CSA-AKI on long-term survival is known [8], the modifying influence of early recovery of renal function is unclear. We therefore tested the hypothesis that early recovery of renal function after AKI is independently associated with improved long-term survival in patients undergoing cardiac operations. Material and Methods The study was approved by the Duke University Institutional Review Board as a retrospective, observational cohort study. The requirement for informed consent was waived. A study protocol with the specified hypothesis was submitted before data retrieval and analysis. Data Sources Detailed clinical, laboratory, and outcomes data were obtained from prospectively entered databases for consecutive adult patients undergoing coronary artery by by The Society of Thoracic Surgeons /10/$36.00 Published by Elsevier Inc doi: /j.athoracsur

2 Ann Thorac Surg SWAMINATHAN ET AL 2010;89: RENAL RECOVERY AND POST-CABG SURVIVAL 1099 pass grafting (CABG) operations at Duke University Medical Center during the 10 years between January 1996 and December Demographic and procedural data were obtained from the Duke Databank for Cardiovascular Diseases, a large, quality-assured data repository for patients undergoing cardiovascular procedures maintained by the Duke Clinical Research Institute, Durham, North Carolina. Serum creatinine values for the perioperative period were obtained from the Duke Clinical Pathology Laboratory. Follow-up was conducted by the Duke Clinical Research Institute Follow-up Services Group and has been previously described [9]. Briefly, this group is responsible for collecting annual follow-up survival data and nonfatal end-point information for the Duke Databank for Cardiovascular Diseases. The annual surveys collect data 6 months after an index visit and yearly thereafter. Follow-up is 95% complete for mortality, and patients who are lost to follow-up (2%) or who have asked to be withdrawn (3%) are submitted for an annual search of the National Death Index. Cause of death is assigned after agreement from independent reviews by an adjudication committee. Specific outcomes for this study were obtained for up to 10 years after the initial operation in all patients and included all-cause mortality. For patients who had more than one surgical revascularization during the follow-up period, only the data pertaining to the first operation was retained. Participant Selection Patients undergoing isolated, elective CABG procedures were selected for this study. To identify a cohort with defined AKI, only those with a peak postoperative creatinine level exceeding 50% of the preoperative (baseline) value were included. Patients requiring renal replacement therapy (RRT) before or after the operation during the index hospitalization were excluded to eliminate the confounding effect of RRT on creatinine values. Those who died before hospital discharge were excluded because they may not have had time to demonstrate a peak in creatinine levels or recovery from AKI. From this subset of patients, those with peak creatinine levels occurring after postoperative day 5 were excluded because they may have had ongoing injury or an additional kidney injury that could compromise functional recovery. Our purpose was to identify a homogenous cohort with CSA-AKI defined to be temporally related to a known event the surgical procedure but not confounded by postoperative influences on renal recovery such as in-hospital death, dialysis, or a peak in creatinine after day 5. Renal Function Variables CREATININE VALUES. The initial cohort of patients selected from the Duke Databank for Cardiovascular Diseases was cross-referenced with the laboratory database to retrieve all creatinine values from 3 days before the operation to 10 days after. Preoperative (baseline) creatinine was defined as the preoperative value closest to the operation. For multiple daily creatinine values, the first value for the day was selected for analysis. Peak postoperative creatinine was defined as the first day of the highest in-hospital creatinine value within the first 5 days after the operation. MISSING VALUES. Creatinine values are often less frequently measured as the hospital stay increases and the patient becomes more stable. Patients with missing creatinine values within the first 3 postoperative days were excluded from the analysis. Starting on postoperative day 4, missing creatinine values were imputed from the previous day s creatinine value. DEFINITION OF AKI. Criteria suggested by the Acute Kidney Injury Network (AKIN) [10] were used to define AKI as an increase of 50% or more in the peak postoperative creatinine level above baseline. In addition, for assessment of distribution of renal recovery according to severity of injury, AKI was also categorized into the AKINrecommended stages based on the percentage change in peak postoperative creatinine above baseline: stage 1, 50% to 100%; stage 2, 100% to 200%; and stage 3, more than 200%. Creatinine values after AKI were used to construct several recovery variables (Table 1). While renal recovery area represented creatinine levels after the peak value and accounted for duration of recovery, the 24- and 48-hour post-peak creatinine values represented early decline in creatinine and early renal recovery. The 24- and 48-hour values of change were characterized as absolute and percentage of peak postoperative creatinine to indicate magnitude of early recovery. Statistical Analyses VARIABLE SELECTION. We characterized early renal recovery using seven different definitions (Table 1). To determine the most clinically relevant recovery variable, we tested the association of each variable with 1-year mortality in a series of multivariable logistic regression models. Each model was adjusted for baseline creatinine, peak postoperative creatinine, and risk score based on the European System for Cardiac Operative Risk Evaluation (EuroSCORE), a validated method of mortality risk prediction for patients undergoing cardiac operations [11, 12]. The covariables were selected a priori and were included in each model regardless of significance so that all models would be comparable. We used the C index of the models to select the most predictive characterization of renal recovery. VALIDATION. To validate the selection of the variable, a bootstrap analysis was performed in which each of the seven multivariable models was fit to 1000 bootstrap samples of the data set. For each bootstrap sample, patient records were randomly sampled from the data set with replacement. Point estimates for the odds ratios and the C indices were obtained for each bootstrap sample. Goodness of fit was assessed for each model with the Hosmer-Lemeshow test. Survival Analysis After identifying the renal recovery variable with greatest predictive ability, we tested the primary hypothesis that early recovery of renal function after AKI is associated

3 1100 SWAMINATHAN ET AL Ann Thorac Surg RENAL RECOVERY AND POST-CABG SURVIVAL 2010;89: Table 1. Creatinine-Based Variables and Definitions of Early Renal Recovery Variable Abbreviation Definition Creatinine variables Pre-op creatinine CrPre Earliest Cr value pre-op Peak post-op creatinine CrMax Highest in-hospital Cr value post-op Discharge creatinine DcCr Cr value at discharge or at post-op day 10, whichever was earlier Post-peak 24-h creatinine p24cr Cr value on first day after CrMax Post-peak 48-h creatinine p48cr Cr value on second day after CrMax Renal recovery variables Renal recovery area RRA Area under curve from CrMax to DcCr Absolute decrease, mg/dl AD CrMax DcCr Percentage decrease PD [(CrMax DcCr)/CrMax] 100 Peak decrease 24, mg/dl PkD24 CrMax p24cr Percentage decrease 24 PD24 [(CrMax p24cr)/crmax] 100 Peak decrease 48, mg/dl PkD48 CrMax p48cr Percentage decrease 48 PD48 [(CrMax p48cr)/crmax] 100 with improved long-term survival. A survival curve was constructed for the entire follow-up period using the Kaplan-Meier method, with start time as the date of the operation and time to death as the principal outcome. Further investigation with Cox proportional hazards regression analysis tested the association of the selected recovery variable and long-term survival adjusting for preoperative body weight, EuroSCORE, preoperative creatinine, peak postoperative creatinine, and cardiopulmonary bypass time. Patients who did not die within the study follow-up period were considered censored at the point of the last follow-up. Proportional hazards assumptions were tested with an interaction between the difference between the peak creatinine and the value at the next 24 hours as a percentage of the peak value (PD24) and the log of the study follow-up time. Significance was assessed at a two-tailed value of p All statistical analyses were conducted using SAS software (SAS Institute Inc, Cary, NC). Odds ratios (OR) and hazard ratios (HR) are presented with 95% confidence intervals (CI). Results Between January 1996 and December 2005, 10,275 consecutive elective, isolated CABG procedures were performed. From this population, 1113 patients who met inclusion criteria for CSA-AKI constituted the principal study cohort. According to exclusion criteria, 146 patients died in-hospital postoperatively, 502 received perioperative RRT (444 preoperatively and 58 more postoperatively), the postoperative creatinine change in 8481 patients did not exceed 50%, and the postoperative creatinine level in 33 patients peaked after postoperative day 5. Survival status was determined for 1111 patients with a median follow-up time of 40 months. Characteristics of the CSA-AKI study population, including key renal function variables, are reported in Table 2. AKI was at stage 1 in 799 patients, stage 2 in 264, and stage 3 in 50. The 1-year mortality rate was 8% (n 91). Multivariable logistic regression models for 1-year mortality were developed for the seven renal recovery variables (Table Table 2. Perioperative Characteristics of Study Population, Including Key Renal Function Variables Variable Value a Mean (SD) or % Range Age, y 65.9 (10.4)... Female sex White race Weight, kg 87.5 (20.1)... Diabetes Hypertension History of Myocardial infarction Stroke Smoking Congestive heart failure Preoperative aspirin use CPB time, min (55.8)... Cross-clamp time, min 65.0 (28.0)... Hyperlipidemia Ejection fraction (0.159)... COPD Peripheral vascular disease Creatinine variables, mg/dl Pre-op creatinine 1.07 (0.32) Peak post-op creatinine 2.06 (0.87) Discharge creatinine 1.28 (0.47) Post-peak 24-hour creatinine 1.69 (0.80) Post-peak 48-hour creatinine 1.46 (0.68) a Data are presented as mean values with standard deviation in parentheses or percentage of population where appropriate. CPB cardiopulmonary bypass; COPD chronic obstructive pulmonary disease.

4 Ann Thorac Surg SWAMINATHAN ET AL 2010;89: RENAL RECOVERY AND POST-CABG SURVIVAL 1101 Table 3. Multivariable Logistic Regression Model of the Independent Association of Renal Recovery Variables With 1-year Mortality Variable a Coefficient OR (95% CI) p Value C Index Boot-strapped C Index Renal recovery area ( ) Peak decrease ( ) Peak decrease ( ) Absolute decrease ( ) Percentage decrease ( ) Percentage decrease ( ) Percentage decrease ( ) a Definitions of variables are provided in Table 1. CI confidence interval; OR odds ratio. 3). The PD24 (Table 1) was the recovery variable that showed the strongest negative association with 1-year mortality (OR estimate per unit change, 0.97; 95% CI, 0.95 to 0.99; p 0.002) with the highest C index (0.72). Peak postoperative creatinine (p 0.01) and EuroSCORE index (p ) were also significantly associated with 1-year mortality in this model. Bootstrap analysis showed that in 84% of samples, the recovery variable with the strongest negative association with 1-year survival was PD24 (C index, 0.729). The Hosmer-Lemeshow test revealed that values for all models were non-significant, with no differences between observed and expected frequencies of events, thereby indicating adequate goodness of fit. The distribution of PD24 for the entire CSA- AKI population and among the three AKI stages is shown in Figure 1. Survival data using the Kaplan-Meier method demonstrated a median survival time of 40 months for the cohort (Fig 2), with a maximum follow-up of 135 months. During the follow-up, 316 patients died, and the 797 patients who did not die were censored at the time of the last follow-up. Patients at risk at each 12-month point are shown in Figure 2. After adjustment for EuroSCORE, preoperative creatinine, peak postoperative creatinine, weight, and cardiopulmonary bypass time, the Cox proportional hazards regression model showed a significant negative association between PD24 and long-term mortality (HR for a 10% unit change, 0.82; 95% CI, 0.74 to 0.90; Table 4). Assumptions of proportional hazards were satisfied (Wald 2, 2.29; p 0.13) indicating that we did not reject the null hypothesis. Comment The present study confirmed our hypothesis that early recovery of renal function after AKI is associated with improved long-term survival in patients undergoing cardiac operations. Because strategies to prevent CSA-AKI have been largely unsuccessful, early recovery of function may therefore represent a new focus for intervention that alters the risk of long-term death associated with AKI. Recovery of renal function is not well characterized, and its long-term effects are even less clear. In a study primarily designed to assess the effect of CSA-AKI on 30-day mortality, Lassnigg and colleagues [13] found that patients with a negative change in postoperative creatinine had the lowest mortality rate. Although their study did not examine recovery from AKI, they showed that a negative change in creatinine was associated with improved survival. Recently, Bihorac and colleagues [14] reported that patients with partial or complete recovery after postoperative AKI were at a lower risk of long-term death compared with those that had no recovery. Their study defined recovery using a ratio of discharge to baseline creatinine and included patients undergoing cardiovascular operations. In a meta-analysis of renal recovery after AKI, Schmitt and colleagues [15] reported that age was a major factor associated with a lower likelihood of recovery of renal function. They acknowledged their study was limited by variable definitions of AKI, renal recovery, and time to renal recovery, and insufficient data on baseline creatinine and comorbidity scores. Other studies of AKI have used a relatively firm definition of renal recovery that of freedom from dialysis [16 20]. The use of this variable as a definition of renal recovery, however, limits data to only those who have severe AKI requiring RRT and does not provide information on the larger group of patients who have smaller but important decrements in renal function. Our study, in contrast, adds significantly to current knowledge on early renal recovery in a large, homogenous population of CABG patients with standard definitions of CSA-AKI based on detailed creatinine data. These data were used to develop specific characterizations of renal recovery that are clinically meaningful and were validated in their association with outcome. Functional recovery of the kidneys is well documented, and the capacity of the kidney to use endogenous mechanisms for repair and regeneration has been recognized [21 23]. Although the precise mechanisms of renal cellular repair remain unclear, the concept of endogenous repair after an acute insult is vitally important. The ability of organs to repair themselves after an injury represents a survival response, and a greater ability to recover from an insult may be reflected in improved overall survival. The renal recovery variable in our study

5 1102 SWAMINATHAN ET AL Ann Thorac Surg RENAL RECOVERY AND POST-CABG SURVIVAL 2010;89: Fig 1. Frequency distribution is shown of early renal recovery, defined as the percentage decrease in creatinine 24 hours after its peak value (PD24) in the (A) entire study population, and in the subsets of patients grouped according to severity of acute kidney injury (AKI) based on standard criteria of (B) stage I, (C) stage II, and (D) stage III. with the strongest negative association with 1-year mortality was PD24, reflecting the importance of the magnitude of early recovery of renal function. In contrast, other variables based on more gradual recovery did not influence survival after AKI to the same degree. Our findings suggest that when the delicate balance between ongoing injury and early repair tilts in favor of repair, the magnitude of this early reversal of injury significantly alters the risk of death. Mechanisms that control the magnitude of early recovery after a renal insult may therefore have a major effect in survival after AKI. The principal strengths of our study are the use of a large cohort of CABG patients with standardized definitions of AKI from a quality-controlled database with robust follow-up methods. However, our study also has certain limitations associated with the study design and measurement of renal function. Our findings apply to a relatively homogenous CABG population limited by our strict selection criteria and may not be generalizable across the entire spectrum of patients encountered in clinical practice. However, our findings encourage the search for the value of early renal recovery after AKI in other similar populations. Although the study was retrospective and data collection was not hypothesis-driven, data were prospectively collected and continuously validated to enable outcomes measurement. Serum creatinine as a biomarker of renal function has well-known limitations. More sensitive biomarkers of renal injury have been identified, including interleukin- 18, neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, and cystatin C [24]. Although these biomarkers are indeed sensitive to subtle changes in kidney function, they have not yet been validated as independent markers of adverse long-term outcomes in contrast to creatinine, probably because decreases in creatinine occur well after renal function has already declined, indicating a clinically relevant injury. Moreover, other biomarkers have also not yet been investigated as indicators of renal recovery, and creatinine remains the current standard on which clinical management is based. An important contribution of this study is that it further characterizes patterns of renal response to peri-

6 Ann Thorac Surg SWAMINATHAN ET AL 2010;89: RENAL RECOVERY AND POST-CABG SURVIVAL 1103 Fig 2. Separate survival curves are shown for long-term survival according to early renal recovery, as defined by the percentage decrease in creatinine 24 hours after its peak value (PD24) of 9% (black line), 18% (dashed gray line), and 26% (solid gray line), representing the 25th, 50th, and 75th percentiles, respectively. operative insult independent from current definitions of AKI while significantly supplementing their ability to predict the risk of death. Also notable is that this information on early serum creatinine decline is often immediately available to intensivists as the peak is recognized (presuming daily evaluation). To demonstrate the importance of this concept, we inserted hypothetic serum creatinine values typically seen perioperatively in our primary model (Fig 3). The following example illustrates the significance of early renal recovery. Patients A and B have identical baseline serum creatinine values of 1 mg/dl and sustain similar AKI, reflected by peak postoperative creatinine values of 3.0 mg/dl (an example of stage 3 AKI). Without additional data, assuming a mean EuroSCORE and an approximately average creatinine decline over the subsequent 24 hours (PD24) of 20% to 2.4 mg/dl, the predicted mortality risk at 1 year for both patients would Table 4. Cox Proportional Hazards Regression Model Including Early Recovery of Renal Function a and Other Variables Associated With Long-Term Postoperative Mortality Variable HR (95% CI) p Value PD ( ) Peak post-op creatinine 1.23 ( ) Pre-op creatinine 1.47 ( ) 0.04 EuroSCORE 1.15 ( ) CPB time 1.00 ( ) 0.16 Weight 0.99 ( ) a Defined as the percentage decrease in the creatinine level 24 hours after its peak value (PD24) CI confidence interval; CPB cardiopulmonary bypass; Euro- SCORE European System for Cardiac Operative Risk Evaluation; HR hazard ratio; PD24 see footnote a. Fig 3. The effect of early renal recovery on the mortality risk is shown by inserting hypothetical values for preoperative creatinine (1.0 mg/dl),with peak postoperative creatinine levels of 1.5, 2.0, and 3.0 mg/dl as examples of acute kidney injury (AKI) stages I (diamonds), II (squares), and III (triangles), respectively, and mean European System for Cardiac Operative Risk Evaluation (EuroSCORE) inserted into the primary model. Predicted 1-year mortality was calculated for each AKI stage based on three different values (10%, 20%, and 30%) of PD24, defined as percentage decrease in creatinine 24 hours after its peak value. be 7.9%. However, if by the next day the serum creatinine in patient A declines instead to 2.1 mg/dl, whereas in patient B the decline is to 2.7 mg/dl, reflecting PD24 values of 30% and 10%, respectively, their predicted mortality risks are significantly different. The accelerated renal recovery reflected in patient A is associated with a reduced mortality risk of 5.7%, whereas the slower recovery for patient B portends an almost twofold higher mortality risk of 10.8%. Thus, in our study more rapid recovery of renal filtration after the maximum insult, although reflecting a net sum of ongoing injury and a potentially more robust renal recovery profile, translates into a clinically important survival advantage 1 year after the operation. For cardiac surgeons and intensivists, the post-peak decline is a clinically useful value in that it improves the ability to predict long-term mortality risk based on the magnitude of early recovery. We could then use this value to improve postoperative surveillance if patients do not show sufficient early recovery. The next steps could include elucidation of modifiable perioperative factors that influence early renal recovery and assessment of interventions that target such factors, including mechanisms of renal repair and regeneration. Indeed, given the limited success of interventions that prevent CSA-AKI, improvement in early renal recovery may represent a novel and valid therapeutic goal. In summary, our study found that early recovery of renal function is associated with improved long-term survival after postoperative AKI in CABG patients. Given the high mortality risk associated with postoperative AKI, early renal recovery seems to offer a distinct survival benefit and may represent a novel therapeutic target.

7 1104 SWAMINATHAN ET AL Ann Thorac Surg RENAL RECOVERY AND POST-CABG SURVIVAL 2010;89: Markers of early renal recovery should also be incorporated into studies that examine the effect of AKI on adverse outcomes. References 1. Loef BG, Epema AH, Smilde TD, et al. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol 2005;16: Cooper WA, O Brien SM, Thourani VH, et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation 2006;113: Shaw A, Swaminathan M, Stafford-Smith M. Cardiac surgery-associated acute kidney injury: putting together the pieces of the puzzle. Nephron Physiol 2008;109:p Bagshaw SM, Mortis G, Godinez-Luna T, Doig CJ, Laupland KB. Renal recovery after severe acute renal failure. Int J Artif Organs 2006;29: Theriault J, Agharazzi M, Dumont M, et al. Atheroembolic renal failure requiring dialysis: potential for renal recovery? A review of 43 cases. Nephron Clin Pract 2003;94:c Albright RC Jr, Smelser JM, McCarthy JT, et al. Patient survival and renal recovery in acute renal failure: randomized comparison of cellulose acetate and polysulfone membrane dialyzers. Mayo Clin Proc 2000;75: Bagshaw SM, Laupland KB, Doig CJ, et al. Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study. Crit Care 2005;9:R Brown JR, Cochran RP, MacKenzie TA, et al. Long-term survival after cardiac surgery is predicted by estimated glomerular filtration rate. Ann Thorac Surg 2008;86: Swaminathan M, Morris RW, De Meyts DD, et al. Deterioration of regional wall motion immediately after coronary artery bypass graft surgery is associated with long-term major adverse cardiac events. Anesthesiology 2007;107: Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11:R Nashef SA, Roques F, Michel P, et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999;16: Biancari F, Kangasniemi OP, Luukkonen J, et al. EuroSCORE predicts immediate and late outcome after coronary artery bypass surgery. Ann Thorac Surg 2006;82: Lassnigg A, Schmid ER, Hiesmayr M, et al. Impact of minimal increases in serum creatinine on outcome in patients after cardiothoracic surgery: do we have to revise current definitions of acute renal failure? Crit Care Med 2008;36: Bihorac A, Yavas S, Subbiah S, et al. Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg 2009;249: Schmitt R, Coca S, Kanbay M, et al. Recovery of kidney function after acute kidney injury in the elderly: a systematic review and meta-analysis. Am J Kidney Dis 2008;52: Bell M, Granath F, Schon S, Ekbom A, Martling CR. Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure. Intensive Care Med 2007;33: Cosentino F, Chaff C, Piedmonte M. Risk factors influencing survival in ICU acute renal failure. Nephrol Dial Transplant 1994;9(suppl 4): Silvester W, Bellomo R, Cole L. Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med 2001;29: Spurney RF, Fulkerson WJ, Schwab SJ. Acute renal failure in critically ill patients: prognosis for recovery of kidney function after prolonged dialysis support. Crit Care Med 1991; 19: Uchino S, Bellomo R, Morimatsu H, et al. Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med 2007;33: Kale S, Karihaloo A, Clark PR, et al. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest 2003;112: Ishibe S, Cantley LG. Epithelial-mesenchymal-epithelial cycling in kidney repair. Curr Opin Nephrol Hypertens 2008; 17: Gupta S, Verfaillie C, Chmielewski D, Kim Y, Rosenberg ME. A role for extrarenal cells in the regeneration following acute renal failure. Kidney Int 2002;62: Stafford-Smith M, Patel UD, Phillips-Bute BG, Shaw AD, Swaminathan M. Acute kidney injury and chronic kidney disease after cardiac surgery. Adv Chronic Kidney Dis 2008;15: INVITED COMMENTARY Cardiac surgery associated with acute kidney injury (AKI) is defined as a 0.3 mg/dl or 50% increase in serum creatinine (Cr) from baseline [1], and is one of the most common and complicated adverse events after cardiac surgery [2]. In this paper, Swaminathan and colleagues [3] tackle the associations between early recovery from AKI and long-term survival among patients undergoing elective isolated coronary artery bypass graft (CABG) surgery. Patients with a baseline Cr 2.0 (mg/dl), dialysis before or after CABG, or death prior to discharge were excluded. The cohort included only patients that had AKI develop after cardiac surgery; all others were excluded for the purposes of this analysis. There are several calculations in the analysis readers should review on how to evaluate early renal recovery. These included the highest peak postoperative Cr (CrMax), peak Cr at 24 hours after the CrMax (p24cr) and 48 hours after the CrMax (p48cr), and discharge Cr (DcCr), which were calculated for patients with available Cr data. The percent decrease in Cr at 24 hours after surgery (PD24) was calculated by the following equation: CrMax-p24Cr CrMax 100%. In determining how to interpret the results, the cohort was restricted to elective patients who had AKI develop after cardiac surgery, but not in renal failure before or after the surgery, and who were alive at discharge. The PD24 early recovery measure was identified as the best predictor of reducing the likelihood of 1-year mortality. In Table 3, the continuous form of PD24 was used (odds ratio, 0.97; 95% confidence interval, 0.95 to 0.98), suggesting for each 1% drop in Cr at 24 hours after the max Cr, the likelihood of 1-year mortality is reduced by 3%. In Table 4, PD24 was divided into deciles; the adjusted hazard ratio of 0.82 (95% confidence interval, 0.74 to 0.90) suggests that for each 10% drop in Cr at 24 hours after the CrMax, the likelihood of 1-year mortality is reduced by 2010 by The Society of Thoracic Surgeons /10/$36.00 Published by Elsevier Inc doi: /j.athoracsur

Prognostic impact of uric acid in patients with stable coronary artery disease

Prognostic impact of uric acid in patients with stable coronary artery disease Prognostic impact of uric acid in patients with stable coronary artery disease Gjin Ndrepepa, Siegmund Braun, Martin Hadamitzky, Massimiliano Fusaro, Hans-Ullrich Haase, Kathrin A. Birkmeier, Albert Schomig,

More information

Specialty Excellence Award and America s 100 Best Hospitals for Specialty Care 2013-2014 Methodology Contents

Specialty Excellence Award and America s 100 Best Hospitals for Specialty Care 2013-2014 Methodology Contents Specialty Excellence Award and America s 100 Best Hospitals for Specialty Care 2013-2014 Methodology Contents Introduction... 2 Specialty Excellence Award Determination... 3 America s 100 Best Hospitals

More information

Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care

Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

More information

Cardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone

Cardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone James A. Stone BPHE, BA, MSc, MD, PhD, FRCPC, FAACVPR, FACC Clinical Professor of Medicine, University of Calgary Total Cardiology, Calgary Acknowledgements and Disclosures Acknowledgements Jacques Genest

More information

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg 2 nd Annual Duke Renal Transplant Symposium March 1, 2014 Durham, NC Joseph G. Rogers, M.D. Associate

More information

Patients with end-stage renal disease (ESRD) are at high

Patients with end-stage renal disease (ESRD) are at high Long-Term Outcome of Renal Transplant Recipients in the United States After Coronary Revascularization Procedures Charles A. Herzog, MD; Jennie Z. Ma, PhD; Allan J. Collins, MD Background Retrospective

More information

The sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C:

The sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C: The sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C: The good correlation allows close estimation of GFR Cystatin C GFR GFR in serum estimated* measured* n

More information

Results of streamlined regional ambulance transport and subsequent treatment of acute abdominal aortic aneurysm

Results of streamlined regional ambulance transport and subsequent treatment of acute abdominal aortic aneurysm CHAPTER 6 Results of streamlined regional ambulance transport and subsequent treatment of acute abdominal aortic aneurysm JW Haveman, A Karliczek, ELG Verhoeven, IFJ Tielliu, R de Vos, JH Zwaveling, JJAM

More information

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease PRECOMBAT Trial Seung-Whan Lee, MD, PhD On behalf

More information

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and

More information

Cardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease

Cardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease Cardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease What is Cardiac Rehabilitation? Cardiac rehabilitation is a comprehensive exercise, education, and behavior modification

More information

Main Effect of Screening for Coronary Artery Disease Using CT

Main Effect of Screening for Coronary Artery Disease Using CT Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,

More information

Impact of Massachusetts Health Care Reform on Racial, Ethnic and Socioeconomic Disparities in Cardiovascular Care

Impact of Massachusetts Health Care Reform on Racial, Ethnic and Socioeconomic Disparities in Cardiovascular Care Impact of Massachusetts Health Care Reform on Racial, Ethnic and Socioeconomic Disparities in Cardiovascular Care Michelle A. Albert MD MPH Treacy S. Silbaugh B.S, John Z. Ayanian MD MPP, Ann Lovett RN

More information

Elevated heart rate at twelve months after heart transplantation is an independent predictor of long term mortality

Elevated heart rate at twelve months after heart transplantation is an independent predictor of long term mortality Elevated heart rate at twelve months after heart transplantation is an independent predictor of long term mortality C. Tomas, MA Castel, E Roig, I. Vallejos, C. Plata, F. Pérez-Villa Cardiology Department,

More information

Cardiac Rehabilitation: Strategies Approaching 2020

Cardiac Rehabilitation: Strategies Approaching 2020 ACC Banff 2015 Cardiac Rehabilitation: Strategies Approaching 2020 James A. Stone BPHE, BA, MSc, MD, PhD, FRCPC, FAACVPR, FACC Clinical Professor of Medicine, University of Calgary Libin Cardiovascular

More information

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES Niteesh K. Choudhry, MD, PhD Harvard Medical School Division of Pharmacoepidemiology and Pharmacoeconomics

More information

The American Cancer Society Cancer Prevention Study I: 12-Year Followup

The American Cancer Society Cancer Prevention Study I: 12-Year Followup Chapter 3 The American Cancer Society Cancer Prevention Study I: 12-Year Followup of 1 Million Men and Women David M. Burns, Thomas G. Shanks, Won Choi, Michael J. Thun, Clark W. Heath, Jr., and Lawrence

More information

Tips for surviving the analysis of survival data. Philip Twumasi-Ankrah, PhD

Tips for surviving the analysis of survival data. Philip Twumasi-Ankrah, PhD Tips for surviving the analysis of survival data Philip Twumasi-Ankrah, PhD Big picture In medical research and many other areas of research, we often confront continuous, ordinal or dichotomous outcomes

More information

Omega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9

Omega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9 Omega-3 fatty acids improve the diagnosis-related clinical outcome 1 Critical Care Medicine April 2006;34(4):972-9 Volume 34(4), April 2006, pp 972-979 Heller, Axel R. MD, PhD; Rössler, Susann; Litz, Rainer

More information

Achieving Quality and Value in Chronic Care Management

Achieving Quality and Value in Chronic Care Management The Burden of Chronic Disease One of the greatest burdens on the US healthcare system is the rapidly growing rate of chronic disease. These statistics illustrate the scope of the problem: Nearly half of

More information

Summary HTA. HTA-Report Summary. Introduction

Summary HTA. HTA-Report Summary. Introduction Summary HTA HTA-Report Summary Antioxidative vitamines for prevention of cardiovascular disease for patients after renal transplantation and patients with chronic renal failure Schnell-Inderst P, Kossmann

More information

Sponsor. Novartis Generic Drug Name. Vildagliptin. Therapeutic Area of Trial. Type 2 diabetes. Approved Indication. Investigational.

Sponsor. Novartis Generic Drug Name. Vildagliptin. Therapeutic Area of Trial. Type 2 diabetes. Approved Indication. Investigational. Clinical Trial Results Database Page 1 Sponsor Novartis Generic Drug Name Vildagliptin Therapeutic Area of Trial Type 2 diabetes Approved Indication Investigational Study Number CLAF237A2386 Title A single-center,

More information

Estimated GFR Based on Creatinine and Cystatin C

Estimated GFR Based on Creatinine and Cystatin C Estimated GFR Based on Creatinine and Cystatin C Lesley A Stevens, MD, MS Tufts Medical Center, Tufts University School of Medicine Boston MA Chronic Kidney Disease-Epidemiology Collaboration UO1 DK 053869,

More information

Perioperative Cardiac Evaluation

Perioperative Cardiac Evaluation Perioperative Cardiac Evaluation Caroline McKillop Advisor: Dr. Tam Psenka 10-3-2007 Importance of Cardiac Guidelines -Used multiple times every day -Patient Safety -Part of Surgical Care Improvement Project

More information

Multivariate Logistic Regression

Multivariate Logistic Regression 1 Multivariate Logistic Regression As in univariate logistic regression, let π(x) represent the probability of an event that depends on p covariates or independent variables. Then, using an inv.logit formulation

More information

KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA

KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA O.E. Stakhvoskyi, E.O. Stakhovsky, Y.V. Vitruk, O.A. Voylenko, P.S. Vukalovich, V.A. Kotov, O.M. Gavriluk National Canсer Institute,

More information

ECG may be indicated for patients with cardiovascular risk factors

ECG may be indicated for patients with cardiovascular risk factors eappendix A. Summary for Preoperative ECG American College of Cardiology/ American Heart Association, 2007 A1 2002 A2 European Society of Cardiology and European Society of Anaesthesiology, 2009 A3 Improvement,

More information

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,

More information

Guide to Biostatistics

Guide to Biostatistics MedPage Tools Guide to Biostatistics Study Designs Here is a compilation of important epidemiologic and common biostatistical terms used in medical research. You can use it as a reference guide when reading

More information

Determinants of duration of ICU stay after coronary artery bypass graft surgery

Determinants of duration of ICU stay after coronary artery bypass graft surgery British Journal of Anaesthesia 1996; 77: 208 212 Determinants of duration of ICU stay after coronary artery bypass graft surgery A. MICHALOPOULOS, G. TZELEPIS, G. PAVLIDES, J. KRIARAS, U. DAFNI AND S.

More information

Regression Modeling Strategies

Regression Modeling Strategies Frank E. Harrell, Jr. Regression Modeling Strategies With Applications to Linear Models, Logistic Regression, and Survival Analysis With 141 Figures Springer Contents Preface Typographical Conventions

More information

Current Renal Replacement Therapy in Korea - Insan Memorial Dialysis Registry, 2011 - ESRD Registry Committee, Korean Society of Nephrology*

Current Renal Replacement Therapy in Korea - Insan Memorial Dialysis Registry, 2011 - ESRD Registry Committee, Korean Society of Nephrology* Current Renal Replacement Therapy in Korea - Insan Memorial Dialysis Registry, 2011 - ESRD Registry Committee, Korean Society of Nephrology* =Abstracts= Registry committee of Korean Society of Nephrology

More information

Survival Analysis of Dental Implants. Abstracts

Survival Analysis of Dental Implants. Abstracts Survival Analysis of Dental Implants Andrew Kai-Ming Kwan 1,4, Dr. Fu Lee Wang 2, and Dr. Tak-Kun Chow 3 1 Census and Statistics Department, Hong Kong, China 2 Caritas Institute of Higher Education, Hong

More information

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History Preoperative Cardiac Risk Stratification for Noncardiac Surgery Kimberly Boddicker, MD FACC Essentia Health Heart and Vascular Center 27 th Heart and Vascular Conference May 13, 2011 Objectives Summarize

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Do statins improve outcomes of patients with sepsis and pneumonia? Jordi Carratalà Department of Infectious Diseases Statins for sepsis & community-acquired pneumonia Sepsis and CAP are major healthcare

More information

Cilostazol versus Clopidogrel after Coronary Stenting

Cilostazol versus Clopidogrel after Coronary Stenting Cilostazol versus Clopidogrel after Coronary Stenting Seong-Wook Park, MD, PhD, FACC Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine Seoul, Korea AMC, 2004 Background

More information

06 Validation of risk prediction model

06 Validation of risk prediction model HA Territory-wide PCI Audit 2003-06 06 Validation of risk prediction model PCI Audit Working Group Central Committee (Cardiac Services) HA Convention 2007 Background Participants: All HA hospitals via

More information

The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome

The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome Biomedical & Pharmacology Journal Vol. 6(2), 259-264 (2013) The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome Vadod Norouzi 1, Ali

More information

New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine

New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine Disclosures & Relevant Relationships I have nothing to disclose No financial conflicts Editor,

More information

Data Management. Shanna M. Morgan, MD Department of Laboratory Medicine and Pathology University of Minnesota

Data Management. Shanna M. Morgan, MD Department of Laboratory Medicine and Pathology University of Minnesota Data Management Shanna M. Morgan, MD Department of Laboratory Medicine and Pathology University of Minnesota None Disclosures Objectives History of data management in medicine Review of data management

More information

Zhongmin Li, PhD University of California, Davis School of Medicine Zhongmin.li@ucdmc.ucdavis.edu

Zhongmin Li, PhD University of California, Davis School of Medicine Zhongmin.li@ucdmc.ucdavis.edu Zhongmin Li, PhD University of California, Davis School of Medicine Zhongmin.li@ucdmc.ucdavis.edu 1 Health care quality and transparency of care and outcomes AHRQ s IQI and PSIs State initiatives Multiple

More information

Rehabilitation and Lung Cancer Resection. Roberto Benzo MD MS Mindful Breathing Laboratory Division of Pulmonary & CCM Mayo Clinic

Rehabilitation and Lung Cancer Resection. Roberto Benzo MD MS Mindful Breathing Laboratory Division of Pulmonary & CCM Mayo Clinic Rehabilitation and Lung Cancer Resection Roberto Benzo MD MS Mindful Breathing Laboratory Division of Pulmonary & CCM Mayo Clinic Disclosure Funded by the National Cancer Institute NIH for Preoperative

More information

If several different trials are mentioned in one publication, the data of each should be extracted in a separate data extraction form.

If several different trials are mentioned in one publication, the data of each should be extracted in a separate data extraction form. General Remarks This template of a data extraction form is intended to help you to start developing your own data extraction form, it certainly has to be adapted to your specific question. Delete unnecessary

More information

Albumin and All-Cause Mortality Risk in Insurance Applicants

Albumin and All-Cause Mortality Risk in Insurance Applicants Copyright E 2010 Journal of Insurance Medicine J Insur Med 2010;42:11 17 MORTALITY Albumin and All-Cause Mortality Risk in Insurance Applicants Michael Fulks, MD; Robert L. Stout, PhD; Vera F. Dolan, MSPH

More information

Continuity of Care for Elderly Patients with Diabetes Mellitus, Hypertension, Asthma, and Chronic Obstructive Pulmonary Disease in Korea

Continuity of Care for Elderly Patients with Diabetes Mellitus, Hypertension, Asthma, and Chronic Obstructive Pulmonary Disease in Korea ORIGINAL ARTICLE Medicine General & Social Medicine DOI: 10.3346/jkms.2010.25.9.1259 J Korean Med Sci 2010; 25: 1259-1271 Continuity of Care for Elderly Patients with Diabetes Mellitus, Hypertension, Asthma,

More information

Mitral Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation. Michael Acker, MD For the CTSN Investigators AHA November 2013

Mitral Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation. Michael Acker, MD For the CTSN Investigators AHA November 2013 Mitral Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation Michael Acker, MD For the CTSN Investigators AHA November 2013 Acknowledgements Supported by U01 HL088942 Cardiothoracic

More information

Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes

Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes U.S. Department of Health and Human Services Food and Drug Administration Center

More information

LOGISTIC REGRESSION ANALYSIS

LOGISTIC REGRESSION ANALYSIS LOGISTIC REGRESSION ANALYSIS C. Mitchell Dayton Department of Measurement, Statistics & Evaluation Room 1230D Benjamin Building University of Maryland September 1992 1. Introduction and Model Logistic

More information

1.0 Abstract. Title: Real Life Evaluation of Rheumatoid Arthritis in Canadians taking HUMIRA. Keywords. Rationale and Background:

1.0 Abstract. Title: Real Life Evaluation of Rheumatoid Arthritis in Canadians taking HUMIRA. Keywords. Rationale and Background: 1.0 Abstract Title: Real Life Evaluation of Rheumatoid Arthritis in Canadians taking HUMIRA Keywords Rationale and Background: This abbreviated clinical study report is based on a clinical surveillance

More information

CHAPTER THREE COMMON DESCRIPTIVE STATISTICS COMMON DESCRIPTIVE STATISTICS / 13

CHAPTER THREE COMMON DESCRIPTIVE STATISTICS COMMON DESCRIPTIVE STATISTICS / 13 COMMON DESCRIPTIVE STATISTICS / 13 CHAPTER THREE COMMON DESCRIPTIVE STATISTICS The analysis of data begins with descriptive statistics such as the mean, median, mode, range, standard deviation, variance,

More information

Nierfunctiemeting en follow-up van chronisch nierlijden

Nierfunctiemeting en follow-up van chronisch nierlijden Nierfunctiemeting en follow-up van chronisch nierlijden 12 Jan 2016 Patrick Peeters, M.D. Dept Nephrology Ghent University Hospital Plan of presentation 1/ Renal function determination: Measured GFR Estimated

More information

Common Surgical Procedures in the Elderly

Common Surgical Procedures in the Elderly Common Surgical Procedures in the Elderly From hip and knee replacements to cataract and heart surgery, America s elderly undergo 20% of all surgical procedures. For a group that comprises only 13% of

More information

Endoskopische Venenentnahme der V. saphena in der koronaren Bypasschirurgie - Aktuelle Datenlage - Dr. med. Stefanie Reutter

Endoskopische Venenentnahme der V. saphena in der koronaren Bypasschirurgie - Aktuelle Datenlage - Dr. med. Stefanie Reutter Endoskopische Venenentnahme der V. saphena in der koronaren Bypasschirurgie - Aktuelle Datenlage - Dr. med. Stefanie Reutter Endoskopische Venenentnahme (EVH) - Einführung 1979 Tevaearai und Kollegen haben

More information

Perfusion Downunder Collaboration Database Data Quality Assurance: Towards a High Quality Clinical Database

Perfusion Downunder Collaboration Database Data Quality Assurance: Towards a High Quality Clinical Database The Journal of ExtraCorporeal Technology Perfusion Downunder Collaboration Database Data Quality Assurance: Towards a High Quality Clinical Database Sigrid C. Tuble, PhD, CCRC Department of Cardiac and

More information

on behalf of the AUGMENT-HF Investigators

on behalf of the AUGMENT-HF Investigators One Year Follow-Up Results from AUGMENT-HF: A Multicenter Randomized Controlled Clinical Trial of the Efficacy of Left Ventricular Augmentation with Algisyl-LVR in the Treatment of Heart Failure* Douglas

More information

STROKE PREVENTION IN ATRIAL FIBRILLATION. TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: ABBREVIATIONS: BACKGROUND:

STROKE PREVENTION IN ATRIAL FIBRILLATION. TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: ABBREVIATIONS: BACKGROUND: STROKE PREVENTION IN ATRIAL FIBRILLATION TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To guide clinicians in the selection of antithrombotic therapy for the secondary prevention

More information

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. Hossam Bahy, MD (1992 2012), 19 tools have been identified 11 stroke scores 1

More information

Supplemental Material. Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks

Supplemental Material. Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks Supplemental Material Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks Xin-Min Li, PhD 1, W. H. Wilson Tang, MD 1,2, Marian K. Mosior, PhD 3, Ying Huang,

More information

Pre-Operative Cardiac Evaluation Kalpana Jain, MD

Pre-Operative Cardiac Evaluation Kalpana Jain, MD Pre-Operative Cardiac Evaluation Kalpana Jain, MD Cardiac evaluation is an integral part of pre-op evaluation. Perioperative cardiac events are common causes of mortality. Major cardiac complications associated

More information

COMMON METHODOLOGICAL ISSUES FOR CER IN BIG DATA

COMMON METHODOLOGICAL ISSUES FOR CER IN BIG DATA COMMON METHODOLOGICAL ISSUES FOR CER IN BIG DATA Harvard Medical School and Harvard School of Public Health sharon@hcp.med.harvard.edu December 2013 1 / 16 OUTLINE UNCERTAINTY AND SELECTIVE INFERENCE 1

More information

HA Territory-wide PCI Audit 2003-05

HA Territory-wide PCI Audit 2003-05 HA Territory-wide PCI Audit 23-5 5 PCI Audit Working Group Central Committee (Cardiac Services) HA Convention 26 Percutaneous Coronary Intervention Background HA AP target 2/3, coordinated by PCI Working

More information

The Management of a Clinical T1b Renal Tumor in the Presence of a Normal Contralateral Kidney

The Management of a Clinical T1b Renal Tumor in the Presence of a Normal Contralateral Kidney Opposing Views The Management of a Clinical T1b Renal Tumor in the Presence of a Normal Contralateral Kidney NEPHRON SPARING SURGERY When a patient is seated in front of you with a6cm contrast enhancing

More information

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.

This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. abcd Clinical Study for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis which is part of the clinical

More information

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with

More information

STROKE PREVENTION IN ATRIAL FIBRILLATION

STROKE PREVENTION IN ATRIAL FIBRILLATION STROKE PREVENTION IN ATRIAL FIBRILLATION OBJECTIVE: To guide clinicians in the selection of antithrombotic therapy for the secondary prevention of ischemic stroke and arterial thromboembolism in patients

More information

8-9-2012. In hospital diabetes care background and challenges. Duality of interest. One of the goals may be...

8-9-2012. In hospital diabetes care background and challenges. Duality of interest. One of the goals may be... In hospital diabetes care background and challenges Duality of interest Nothing to disclose within the framework of this presentation My own fasting BG is 4.6 mmol/l, HbA1c 5.4% Bruce H.R. Wolffenbuttel

More information

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains

More information

The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery

The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery Michael E. Farkouh, MD, MSc Peter Munk Chair in Multinational Clinical Trials Director, Heart and Stroke

More information

Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery q

Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery q European Journal of Cardio-thoracic Surgery 22 (2002) 101 105 www.elsevier.com/locate/ejcts Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery

More information

Service delivery interventions

Service delivery interventions Service delivery interventions S A S H A S H E P P E R D D E P A R T M E N T O F P U B L I C H E A L T H, U N I V E R S I T Y O F O X F O R D CO- C O O R D I N A T I N G E D I T O R C O C H R A N E E P

More information

Surgeons Role in Atrial Fibrillation

Surgeons Role in Atrial Fibrillation Atrial Fibrillation Surgeons Role in Atrial Fibrillation Steven J Feldhaus, MD, FACS 2015 Cardiac Symposium September 18, 2015 Stages of Atrial Fibrillation Paroxysmal (Intermittent) Persistent (Continuous)

More information

Appendix: Description of the DIETRON model

Appendix: Description of the DIETRON model Appendix: Description of the DIETRON model Much of the description of the DIETRON model that appears in this appendix is taken from an earlier publication outlining the development of the model (Scarborough

More information

Five things to watch in nephrology. David Sheikh-Hamad, MD Professor of Medicine, Molecular & Cellular Biology Baylor College of Medicine

Five things to watch in nephrology. David Sheikh-Hamad, MD Professor of Medicine, Molecular & Cellular Biology Baylor College of Medicine Five things to watch in nephrology David Sheikh-Hamad, MD Professor of Medicine, Molecular & Cellular Biology Baylor College of Medicine Financial Disclosures David Sheikh-Hamad, MD In the context of my

More information

User Guide. A. Program Summary B. Waiting List Information C. Transplant Information

User Guide. A. Program Summary B. Waiting List Information C. Transplant Information User Guide This report contains a wide range of useful information about the pancreas transplant program at Saint Louis University Hospital (MOSL). The report has three main sections: A. Program Summary

More information

Temporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008

Temporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008 Special Report Temporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008 Matthew B. Schabath, PhD, Zachary J. Thompson, PhD,

More information

Predictive Analytics: 'A Means to Harnessing the Power to Drive Healthcare Value

Predictive Analytics: 'A Means to Harnessing the Power to Drive Healthcare Value Predictive Analytics: 'A Means to Harnessing the Power to Drive Healthcare Value Wolf H. Stapelfeldt, MD Chairman, Department of General Anesthesiology Cleveland Clinic Vice Chairman, Surgical Operations,

More information

Denominator Statement: Cardiac surgery patients with no evidence of prior infection.

Denominator Statement: Cardiac surgery patients with no evidence of prior infection. Last Updated: Version 4.3b NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Information Form CMS/The Joint Commission: Suspended (Effective immediately beginning with July 1, 2014 discharges)

More information

Chi Squared and Fisher's Exact Tests. Observed vs Expected Distributions

Chi Squared and Fisher's Exact Tests. Observed vs Expected Distributions BMS 617 Statistical Techniques for the Biomedical Sciences Lecture 11: Chi-Squared and Fisher's Exact Tests Chi Squared and Fisher's Exact Tests This lecture presents two similarly structured tests, Chi-squared

More information

Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus

Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Number 84 Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus Summary Overview Clinical

More information

Series 1 Case Studies Adverse Events that Represent Unanticipated Problems: Reporting Required

Series 1 Case Studies Adverse Events that Represent Unanticipated Problems: Reporting Required Welcome! This document contains three (3) series of Case Study examples that will demonstrate all four OHSU reporting categories (#1 4) as well as examples of events that are considered not reportable.

More information

How can registries contribute to guidelines? Nicolas DANCHIN, HEGP, Paris

How can registries contribute to guidelines? Nicolas DANCHIN, HEGP, Paris How can registries contribute to guidelines? Nicolas DANCHIN, HEGP, Paris Pros and cons of registers Prospective randomised trials constitute the cornerstone of "evidence-based" medicine, and they therefore

More information

Quantifying Life expectancy in people with Type 2 diabetes

Quantifying Life expectancy in people with Type 2 diabetes School of Public Health University of Sydney Quantifying Life expectancy in people with Type 2 diabetes Alison Hayes School of Public Health University of Sydney The evidence Life expectancy reduced by

More information

CSI-AKI: the magnitude of the phenomenon Risk factors for CSI-AKI Perfusion-related risk factors What the perfusionist should avoid and what

CSI-AKI: the magnitude of the phenomenon Risk factors for CSI-AKI Perfusion-related risk factors What the perfusionist should avoid and what Cardiac surgery induced acute kidney injury and the perfusionist M. Ranucci Director of Clinical Research Dept of Cardiothoracic and Vascular Anesthesia and Intensive Care IRCCS Policlinico S.Donato Ranuuci,

More information

Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial

Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial Connie N. Hess, MD, MHS, Stefan James, MD, PhD, Renato D. Lopes, MD, PhD, Daniel M. Wojdyla,

More information

Barriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness

Barriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness Barriers to Healthcare Services for People with Mental Disorders Cardiovascular disorders and diabetes in people with severe mental illness Dr. med. J. Cordes LVR- Klinikum Düsseldorf Kliniken der Heinrich-Heine-Universität

More information

Randomized trials versus observational studies

Randomized trials versus observational studies Randomized trials versus observational studies The case of postmenopausal hormone therapy and heart disease Miguel Hernán Harvard School of Public Health www.hsph.harvard.edu/causal Joint work with James

More information

Listen to your heart: Good Cardiovascular Health for Life

Listen to your heart: Good Cardiovascular Health for Life Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular

More information

Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better

Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better Cardiac Rehabilitation: An Under-utilized Resource Making Patients Live Longer, Feel Better Marian Taylor, M.D. Medical University of South Carolina Director, Cardiac Rehabilitation I have no disclosures.

More information

The author has no disclosures

The author has no disclosures Mary Bradbury, PharmD, BCPS Clinical Pharmacy Specialist, Cardiac Surgery September 18, 2012 Mary.bradbury@inova.org This presentation will discuss unlabeled and investigational use of products The author

More information

Group Accident Insurance

Group Accident Insurance Group Accident Insurance An accident insurance plan provides benefits to help cover the costs associated with unexpected bills. This plan pays over and above medical and can purchase without having medical

More information

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION NEW ENGLAND JOURNAL OF MEDICINE 2011; DOI: 10.

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION NEW ENGLAND JOURNAL OF MEDICINE 2011; DOI: 10. FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION NEW ENGLAND JOURNAL OF MEDICINE 2011; DOI: 10.1056/NEJMSA1107913 Niteesh K. Choudhry, MD, PhD, 1 Jerry Avorn, MD, 1 Robert J. Glynn,

More information

Descriptive Statistics

Descriptive Statistics Descriptive Statistics Primer Descriptive statistics Central tendency Variation Relative position Relationships Calculating descriptive statistics Descriptive Statistics Purpose to describe or summarize

More information

Greg Peterson, MPA, PhD candidate Melissa McCarthy, PhD Presentation for 2013 AcademyHealth Annual Research Meeting

Greg Peterson, MPA, PhD candidate Melissa McCarthy, PhD Presentation for 2013 AcademyHealth Annual Research Meeting Greg Peterson, MPA, PhD candidate Melissa McCarthy, PhD Presentation for 2013 AcademyHealth Annual Research Meeting Medicare Coordinated Care Demonstration (MCCD) Established in Balanced Budget Act of

More information

The Role of Insurance in Providing Access to Cardiac Care in Maryland. Samuel L. Brown, Ph.D. University of Baltimore College of Public Affairs

The Role of Insurance in Providing Access to Cardiac Care in Maryland. Samuel L. Brown, Ph.D. University of Baltimore College of Public Affairs The Role of Insurance in Providing Access to Cardiac Care in Maryland Samuel L. Brown, Ph.D. University of Baltimore College of Public Affairs Heart Disease Heart Disease is the leading cause of death

More information

Description of problem Description of proposed amendment Justification for amendment ERG response

Description of problem Description of proposed amendment Justification for amendment ERG response KEY INACCURACIES Issue 1 Distinguishing between groups of STEMI patients Key issue throughout the report The ERG distinguishes between groups of STEMI patients defining four patient groups: STEMI without

More information

Atherosclerosis of the aorta. Artur Evangelista

Atherosclerosis of the aorta. Artur Evangelista Atherosclerosis of the aorta Artur Evangelista Atherosclerosis of the aorta Diagnosis Classification Prevalence Risk factors Marker of generalized atherosclerosis Risk of embolism Therapy Diagnosis Atherosclerosis

More information

Health risk assessment: a standardized framework

Health risk assessment: a standardized framework Health risk assessment: a standardized framework February 1, 2011 Thomas R. Frieden, MD, MPH Director, Centers for Disease Control and Prevention Leading causes of death in the U.S. The 5 leading causes

More information

Progressive Care Insurance for life A NEW TYPE OF INSURANCE

Progressive Care Insurance for life A NEW TYPE OF INSURANCE Progressive Care Insurance for life A NEW TYPE OF INSURANCE New Progressive Care from Sovereign Progressive Care is a type of insurance that is new to New Zealand. It s not a traditional all-or-nothing

More information

Heart transplantation

Heart transplantation Heart transplantation A patient s guide 1 Heart transplantation Heart transplantation has the potential to significantly improve the length and quality of life for patients with severe heart failure.

More information

Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements

Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements Salmaan Kanji, Pharm.D. The Ottawa Hospital The Ottawa Hospital Research Institute Conflict of Interest No financial, proprietary

More information